CheckMate 8HW
CheckMate 8HW: Interim Analysis of Phase III Trial of Nivolumab + Ipilimumab vs Nivolumab for MSI-H or dMMR mCRC

Released: February 04, 2025

Expiration: August 03, 2025

Activity

Progress
1
Course Completed